134 related articles for article (PubMed ID: 2421865)
1. Successful treatment of good-risk disseminated testicular cancer with cisplatin, bleomycin, and reduced-dose vinblastine.
Pizzocardo G; Salvioni R; Zanoni F; Milani A; Piva L
Cancer; 1986 Jun; 57(11):2114-8. PubMed ID: 2421865
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin, etoposide, bleomycin first-line therapy and early resection of residual tumor in far-advanced germinal testis cancer.
Pizzocaro G; Piva L; Salvioni R; Zanoni F; Milani A
Cancer; 1985 Nov; 56(10):2411-5. PubMed ID: 2412683
[TBL] [Abstract][Full Text] [Related]
3. Early resection of residual tumor during cisplatin, vinblastine, bleomycin combination chemotherapy in stage III and bulky stage II nonseminomatous testicular cancer.
Pizzocaro G; Salvioni R; Pasi M; Zanoni F; Milani A; Pilotti S; Monfardini S
Cancer; 1985 Jul; 56(2):249-55. PubMed ID: 2408728
[TBL] [Abstract][Full Text] [Related]
4. High-dose versus low-dose vinblastine in cisplatin-vinblastine-bleomycin combination chemotherapy of non-seminomatous testicular cancer: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group.
Stoter G; Sleyfer DT; ten Bokkel Huinink WW; Kaye SB; Jones WG; van Oosterom AT; Vendrik CP; Spaander P; de Pauw M; Sylvester R
J Clin Oncol; 1986 Aug; 4(8):1199-206. PubMed ID: 2426419
[TBL] [Abstract][Full Text] [Related]
5. Treatment of testicular cancer: a new and improved model.
Einhorn LH
J Clin Oncol; 1990 Nov; 8(11):1777-81. PubMed ID: 1700077
[TBL] [Abstract][Full Text] [Related]
6. A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group study.
Wozniak AJ; Samson MK; Shah NT; Crawford ED; Ford CD; Altman SJ; Stephens RL; Natale RB; Bouroncle BA; Blumenstein BA
J Clin Oncol; 1991 Jan; 9(1):70-6. PubMed ID: 1702148
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy of disseminated germ cell tumors.
Einhorn LH
Cancer; 1987 Aug; 60(3 Suppl):570-3. PubMed ID: 2439185
[TBL] [Abstract][Full Text] [Related]
8. Retroperitoneal lymphadenectomy and aggressive chemotherapy in nonbulky clinical Stage II nonseminomatous germinal testis tumors.
Pizzocaro G; Zanoni F; Milani A; Piva L; Salvioni R; Pasi M; Pilotti S; Monfardini S
Cancer; 1984 Mar; 53(6):1363-8. PubMed ID: 6198070
[TBL] [Abstract][Full Text] [Related]
9. A prospective study of cisplatin-based combination chemotherapy in advanced germ cell malignancy: role of maintenance and long-term follow-up.
Levi JA; Thomson D; Sandeman T; Tattersall M; Raghavan D; Byrne M; Gill G; Harvey V; Burns I; Snyder R
J Clin Oncol; 1988 Jul; 6(7):1154-60. PubMed ID: 2455778
[TBL] [Abstract][Full Text] [Related]
10. Cyclic chemotherapy with cyclophosphamide, doxorubicin, and cisplatin plus vinblastine and bleomycin in advanced germinal tumors. Results with 100 patients.
Logothetis CJ; Samuels ML; Selig DE; Ogden S; Dexeus F; Swanson D; Johnson D; von Eschenbach A
Am J Med; 1986 Aug; 81(2):219-28. PubMed ID: 2426944
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy of disseminated seminoma.
Einhorn LH; Williams SD
Cancer Clin Trials; 1980; 3(4):307-13. PubMed ID: 6159120
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for favorable outcome in disseminated germ cell tumors.
Birch R; Williams S; Cone A; Einhorn L; Roark P; Turner S; Greco FA
J Clin Oncol; 1986 Mar; 4(3):400-7. PubMed ID: 2419524
[TBL] [Abstract][Full Text] [Related]
13. Non-seminomatous germ cell tumors of the testis. Analysis of AFP and HCG production by primary tumors and retroperitoneal lymph node metastases after PVB combination chemotherapy.
Suurmeijer AJ; Oosterhuis JW; Marrink J; De Bruin HW; Schraffordt Koops H; Sleijfer DT; Fleuren GJ
Oncodev Biol Med; 1983; 4(4):289-308. PubMed ID: 6188132
[TBL] [Abstract][Full Text] [Related]
14. Five-year survival of patients with disseminated nonseminomatous testicular cancer treated with cisplatin, vinblastine, and bleomycin.
Stoter G; Vendrik CP; Struyvenberg A; Sleyfer DT; Vriesendorp R; Schraffordt Koops H; van Oosterom AT; ten Bokkel Huinink WW; Pinedo HM
Cancer; 1984 Oct; 54(8):1521-4. PubMed ID: 6206937
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin combination chemotherapy in advanced seminoma.
Pizzocaro G; Salvioni R; Piva L; Zanoni F; Milani A; Faustini M
Cancer; 1986 Oct; 58(8):1625-9. PubMed ID: 2428460
[TBL] [Abstract][Full Text] [Related]
16. Tumour marker concentration at the start of chemotherapy is a stronger predictor of treatment failure than marker half-life: a study in patients with disseminated non-seminomatous testicular cancer.
de Wit R; Sylvester R; Tsitsa C; de Mulder PH; Sleyfer DT; ten Bokkel Huinink WW; Kaye SB; van Oosterom AT; Boven E; Vermeylen K; Stoter G
Br J Cancer; 1997; 75(3):432-5. PubMed ID: 9020492
[TBL] [Abstract][Full Text] [Related]
17. [Clinical results of combination chemotherapy with cisplatin, vinblastine and bleomycin (pvb) for advanced testicular cancer: evaluation of risk criteria].
Mikami K; Nakagawa S; Sugimoto K; Nomoto T; Urano S; Watanabe H; Iwamoto N; Yamazaki S; Hiratake Y; Maegawa M
Hinyokika Kiyo; 1997 Aug; 43(8):561-6. PubMed ID: 9310778
[TBL] [Abstract][Full Text] [Related]
18. Reduced dose PVB treatment of stage IIC-IV testicular seminoma.
Berkmen F
Eur J Surg Oncol; 1993 Feb; 19(1):24-6. PubMed ID: 7679655
[TBL] [Abstract][Full Text] [Related]
19. [Tumor markers as a prognostic factor of the response to treatment in cancer of the testicle].
Germa Lluch JR; Bastus Piulats R
Actas Urol Esp; 1987; 11(3):293-8. PubMed ID: 2444075
[No Abstract] [Full Text] [Related]
20. Cisplatin combination chemotherapy for advanced germ-cell testicular tumours.
Taylor RE; Duncan W; Davey P; Munro AJ; Cornbleet MA
Br J Urol; 1985 Oct; 57(5):567-73. PubMed ID: 2415203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]